Merck Research and Development Expenses 2010-2024 | MRK

Merck research and development expenses for the twelve months ending September 30, 2024 were $22.981B, a 6.88% decline year-over-year.

  • Merck annual research and development expenses for 2023 were $30.531B, a 125.35% increase from 2022.
  • Merck annual research and development expenses for 2022 were $13.548B, a 10.64% increase from 2021.
  • Merck annual research and development expenses for 2021 were $12.245B, a 8.6% decline from 2020.

Merck Research and Development Expenses 2010-2024 | MRK

  • Merck annual research and development expenses for 2023 were $30.531B, a 125.35% increase from 2022.
  • Merck annual research and development expenses for 2022 were $13.548B, a 10.64% increase from 2021.
  • Merck annual research and development expenses for 2021 were $12.245B, a 8.6% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B